Daunorubicin liposomal

N/A

Report date: 2025/03/05 17:39:55

Base Information

Drug NameDaunorubicin liposomal
Drug Alias NameDaunoXomeVS-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsRNA synthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsSarcoma, Kaposi
Global Approved IndicationsSarcoma, Kaposi
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1996/04/08
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesGalen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGalen Limited, Uk
Active IndicationsN/A
Inactive IndicationsSarcoma, Kaposi

Other Information

ATC CodeL01DB02
Related LinksN/A